ABSTRACT
OBJECTIVE: To evaluate the willingness of pregnant women to accept the HPV vaccine for their newborns as well as themselves. METHODS: An 18-item questionnaire was distributed to antepartum women. Demographic data about the respondent's current pregnancy and her knowledge of HPV and the HPV vaccine was collected. Information about the respondent's HPV and HPV vaccine status as well as her acceptance of the vaccine for herself during pregnancy and her newborn son and/or daughter after delivery was also collected. RESULTS: Three hundred surveys were completed and available for review. Only 6 respondents (2%) had received the HPV vaccine. Despite the small group of patients who had previously been vaccinated, 112 respondents (37.3%) stated that they would receive the HPV vaccine during pregnancy if recommended by an obstetrician. 99 respondents (33%) stated that they would vaccinate their newborn female infant and 83 (27.7%) stated would vaccinate their male infants. CONCLUSION: Providing the HPV vaccine to pregnant women as well as newborns could be an important way to increase the patient population who is protected against HPV. A percentage of pregnant women are willing to accept the vaccine for themselves and their newborns.
Subject(s)
Papillomaviridae/immunology , Papillomavirus Infections/prevention & control , Papillomavirus Vaccines/administration & dosage , Patient Acceptance of Health Care/statistics & numerical data , Pregnancy Complications, Infectious/prevention & control , Uterine Cervical Neoplasms/prevention & control , Adolescent , Adult , Female , Health Knowledge, Attitudes, Practice , Humans , Infant, Newborn , Male , Middle Aged , Papillomavirus Infections/immunology , Pregnancy , Pregnancy Complications, Infectious/virology , Surveys and Questionnaires , Uterine Cervical Neoplasms/virology , Vaccination/standards , Young AdultABSTRACT
STUDY OBJECTIVE: To compare the surgical outcome of elderly and younger patients undergoing laparoscopic or robotic surgical staging of endometrial cancer. DESIGN: Retrospective analysis (Canadian Task Force classification II-2). SETTING: University-affiliated hospital. PATIENTS: One hundred twenty-nine patients comprised the study group. Sixty patients were aged 65 years or older (elderly group), and 69 patients were younger than 65 years (younger group). INTERVENTION: Abdominal, laparoscopic, or robotic hysterectomy. MEASUREMENTS AND MAIN RESULTS: Among the 109 patients who underwent laparoscopic or robotic staging, there were no differences in estimated blood loss, lymph node count, surgical time, complications, rate of blood transfusion, conversion to laparotomy, and mean postoperative stay between elderly and younger patients. CONCLUSION: Minimally invasive surgical staging for endometrial cancer is both feasible and safe in the elderly population and offers similar outcomes as in younger patients.
